Great analysis yannpiot.
Besides the possibilities of the repurposed drug heading straight to phase 2 trial is that we have first class very experienced management.
The fact that Garner who is the largest shareholder spent $265,000 at current prices to top up speaks volumes of where he thinks ILA is going.
Also a random called Jason Carroll purchased 5% of the company at a mid 30's price is very encouraging especially as he did not participate in the IPO. All shares bought on market from all the dodgy funds from the IPO.
Ann: Updated Investor Presentation, page-9
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ILA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $28.06M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.0¢ | 17.5¢ | $39.84K | 223.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11350 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 16250 | 1 |
View Market Depth
| Last trade - 15.50pm 14/11/2024 (20 minute delay) ? |
| ILA (ASX) Chart |